ನ್ಯೂರೋಎಂಡೋಕ್ರೈನ್ ಟ್ಯೂಮರ್
Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors
ಎಲ್ಲಿಗೆ ಹೋಗಬೇಕು
ಈ ಟ್ರಯಲ್ಗಾಗಿ ರೋಗಿಗಳನ್ನು ಸೇರಿಸಿಕೊಳ್ಳುತ್ತಿರುವ 2 ಆಸ್ಪತ್ರೆಗಳು India ದಲ್ಲಿವೆ.
ರಿಜಿಸ್ಟ್ರಿ ಸಾರಾಂಶ (ತಾಂತ್ರಿಕ)
Gastro-enteropancreatic Neuro-endocrine tumors (GEP-NETs) are rare slow-growing cancers which commonly involve the abdominal organs like liver, stomach, intestines and pancreas. Their incidence has been documented to have increased over the last decade, thus resulting in treatment options being developed to treat these cancers. These cancers spread commonly to the liver, followed by lungs, bones and other sites. Depending on the extent of disease seen on scan, treatment is planned. Patients are advised Peptide Receptor Radionuclide Therapy (PRRT), which is the current standard of treatment for…
Sponsor: Tata Memorial Hospital
NCT07404176 on ClinicalTrials.gov
ಕೊನೆಯದಾಗಿ 11 Feb 2026 ರಂದು ರಿಜಿಸ್ಟ್ರಿಯಲ್ಲಿ ಅಪ್ಡೇಟ್ ಮಾಡಲಾಗಿದೆ · ನಾವು 20 Oct 2026 ರಂದು ಓದಿದ್ದೇವೆ